TAILIEUCHUNG - INFLUENZA PANDEMIC: Continuity Planning Guide for Canadian Business

It is possible that once efficient human-to-human transmission of H5N1 occurs certain countries may close their borders sporadically believing (rightly or wrongly) that this measure would be effective in reducing the spread of influenza. Screening (with quarantine measures) could be established at borders. If justified by risk/benefit analysis it may be advisable to request employees to consider postponing non-essential travel outside Canada when the pandemic starts. Arrangements may also be required for employees who are stranded outside of the country because borders are closed. In addition, it may be advisable to develop an impact analysis model taking. | Canadian Manufacturers Exporters INFLUENZA PANDEMIC Continuity Planning Guide for Canadian Business March 2006 Canadian Manufacturers Exporters Run by Business For Your Business Disclaimer Canadian Manufacturers Exporters CME has prepared this guide to promote best practices in planning for a possible influenza pandemic. The information is current as of the date of publication. However further work is being undertaken in this area and consequently changes deletions additions or other amendments may be made to this information without notice. Users should check for more up-to-date information on CME s web site and other websites listed in this document. The information in this document is not intended to cover every situation. Details which may be relevant to a user s particular circumstance may have been omitted. Users are advised to seek professional advice before applying any information contained in this document to their own particular circumstances. Users should always obtain appropriate professional advice on the medical issues involved. Canadian Manufacturers Exporters accepts no liability or responsibility for any acts or omissions resulting from reliance in whole or in part on this document. Canadian Manufacturers Exporters disclaims all responsibility or liability to any person whether in contract equity or tort or on any other basis for any direct or indirect losses illness or injury or damage of any kind arising from use of this document. Canadian Manufacturers Exporters is not responsible for the contents or reliability of any websites mentioned in this document and does not necessarily endorse the views expressed in them. Canadian Manufacturers Exporters cannot guarantee that links will work all the time and has no control over the availability of the linked pages. Copyright Canadian Manufacturers Exporters owns the trademark on the cover of this document. Use or reproduction of this trademark is prohibited for any purpose except as .

• Tài chính doanh nghiệp
• Emerging Risks
• Xenotropic Murine
• Leukemia Virus Related
• Blood Borne Pathogens
• Ultrafine and Fine Aerosol
• Safety
• One health
• Emerging infectious diseases
• Animal interface
• The human environment interface
• Zoonotic disease risks
• Henipavirus research
• Carry trade
• Emerging markets
• Currency regime
• Currency intervention
• Currency option
• Public and Pediatrics
• Paediatrics
• People and Politicians
• patient involvement
• risks and benefits
• informed decision
• Wastewater
• Maillard Reaction
• Pros and Cons
• rapidly developing
• Uniqueness of CADASIL
• Research Applications
• Procedural Techniques
• Risks and Complications
• Contrast Related Complications
• health problems
• Conceptual Model
• Carbon Dynamics
• Environmental Carcinogenesis
• Occupational Settings
• Chernobyl Accident
• Detection of Carcinogens